AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines.
The company employs roughly 900 people in Canada who work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head and neck cancer.
The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following core therapy areas: Cardiovascular, Renal and Metabolic diseases (CVRM); Oncology; and Respiratory & Immunology.
In 2019, AstraZeneca invested more than $145 million in Canadian health sciences research in our core therapy areas.
AstraZeneca Canada was named one of Canada’s 10 Most Admired Cultures in 2020 by Waterstone Human Capital – a national award that recognizes best-in-class Canadian organizations with a commitment to strong and vibrant corporate cultures anchored to their people and values. The company was also recognized as being one of the top employers in the Greater Toronto Area – the seventh consecutive year AstraZeneca has received a Greater Toronto Top Employer Award. https://www.astrazeneca.ca/en
At Merck Canada, we are inspired by a shared vision and mission to save and improve lives. To make a difference in the lives of people through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future. https://www.merck.ca/en/home/
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
ca.gsk.com/en-ca/home/@companyWHO WE ARE
Fueled by our human health care mission, we’re an inspired team of innovators relentlessly pursuing ways to improve the lives of patients and their families.
WHAT IS human health care?
It's our way of life at Eisai — giving our first thought to patients and their families. Doing so drives us to create breakthrough solutions and medicines for them.
HOW WE BRING human health care TO LIFE
Breakthrough medicines are just the beginning. human health care sparks a multitude of ways in which we improve the lives of patients, their families and caregivers.
IT’S ONE THING TO TALK ABOUT PUTTING PATIENTS FIRST. IT’S QUITE ANOTHER TO DO IT FOR MORE THAN THREE DECADES.
Eisai came to America in 1987 with one goal in mind: Create innovative new medicines to help patients, their families and caregivers. In 2011, Eisai Canada joined in pursuing this goal. We’ve been breaking through ever since, with solutions and therapies that help improve the lives of the people we serve.
PRODUCTS
How does human health care lead to breakthrough products? The key is understanding the true needs of patients. We know in our hearts how the possibility of a breakthrough can help patients and their families keep fighting. That's why we keep fighting to discover and develop solutions.
Banzel®
Dayvigo™
Lenvima®
Halaven®
Fycompa®
For more information, please visit our website at www.eisai.ca